By: 24-7 Press Release
September 15, 2026
Creative Biolabs Integrates Immunology and Microfluidic Solutions to Support Biotherapeutics Research
SHIRLEY, NY, September 15, 2026 /24-7PressRelease/ -- As biologic modalities continue to diversify, researchers working with antibodies, gene therapies, nanoparticles, and other biotherapeutic candidates face increasingly complex questions surrounding immune-response characterization, functional assessment, and experimental model selection. Complement-related effects, macrophage phenotypes, and the need for more physiologically relevant experimental models are among the considerations that can influence early-stage candidate evaluation and preclinical research strategies.
To address these challenges, Creative Biolabs provides integrated research capabilities spanning anticomplementary activity assessment, macrophage polarization analysis, and customizable microfluidic solutions.
Specialized Immunology Assays for Biotherapeutics Research
• Anticomplementary Activity Assay (ACA)
Complement activation can be an important consideration when evaluating biologics and other therapeutic modalities. Creative Biolabs provides anticomplementary activity assay services to help researchers investigate complement-related effects and generate data for biotherapeutic characterization, formulation assessment, and preclinical risk evaluation.
The service can be tailored to different research needs, enabling scientists to incorporate complement assessment into broader immunological characterization workflows based on candidate type, study design, and research objectives.
• Macrophage Polarization Assay
Macrophages play important roles in inflammation, tumor immunity, tissue remodeling, and responses to therapeutic intervention. Characterizing macrophage phenotypes can therefore provide valuable insights into immune mechanisms and treatment-associated cellular responses.
Creative Biolabs' macrophage polarization assay supports the evaluation of M1/M2-associated phenotypes and polarization-related markers under different experimental conditions. The service can assist researchers studying immunomodulatory compounds, tumor microenvironments, inflammatory mechanisms, and therapy-induced changes in macrophage function.
• Microfluidic Solutions Expand Experimental Possibilities
Alongside its immunology capabilities, Creative Biolabs provides one-stop microfluidic solutions covering custom chip development and a range of microfluidic research applications.
Microfluidic technologies allow researchers to manipulate small sample volumes within precisely controlled environments. Depending on experimental objectives, these systems can help reduce reagent consumption, support miniaturized and higher-throughput assays, and enable dynamic cellular conditions that can be difficult to reproduce with conventional static culture approaches.
By bringing immunological expertise and microfluidic technologies into a broader research workflow, Creative Biolabs can support investigators seeking to assess complement-related responses, characterize macrophage phenotypes, and explore miniaturized or advanced assay formats.
Supporting More Flexible Biotherapeutics Research
Rather than relying on a one-size-fits-all approach, Creative Biolabs works with researchers to select and customize experimental strategies according to specific therapeutic modalities, biological questions, and study objectives.
The combination of specialized immune assays and adaptable microfluidic technologies enables researchers to design more flexible experimental workflows for investigating complex biological interactions while balancing sample requirements, assay throughput, and data-generation needs.
To contact the scientific team to discuss project-specific research requirements, please visit https://www.creative-biolabs.com/complement-therapeutics/.
About Creative Biolabs
Creative Biolabs provides specialized research services for complement biology and complement-targeted therapeutic development. With capabilities spanning complement activation assessment, anticomplementary activity assays, functional characterization, and customized assay development, the company supports researchers investigating complement mechanisms and evaluating therapeutic candidates across diverse research programs.
This contant was orignally distributed by 24-7 Press Release. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Creative Biolabs Integrates Immunology and Microfluidic Solutions to Support Biotherapeutics Research.

